Enlon (Mylan Institutional LLC)
Welcome to the PulseAid listing for the Enlon drug offered from Mylan Institutional LLC. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional LLC |
NON-PROPRIETARY NAME: | edrophonium chloride |
SUBSTANCE NAME: | EDROPHONIUM CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-04-22 |
END MARKETING DATE: | 0000-00-00 |
Enlon HUMAN PRESCRIPTION DRUG Details:
Item Description | Enlon from Mylan Institutional LLC |
LABELER NAME: | Mylan Institutional LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2013-04-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67457-190_91687c49-8f28-499e-9999-9b51154ad379 |
PRODUCT NDC: | 67457-190 |
APPLICATION NUMBER: | ANDA088873 |
Other EDROPHONIUM CHLORIDE Pharmaceutical Manufacturers / Labelers: